Fairvalue-Calculator Fairvalue-Calculator
EN DE

AOTI, Inc (AOTI) Fair Value & Analysis

Healthcare · GB · Market cap 65.8M GBX

Pricep0.6100
Fair Valuep0.1600
Upside-73.8%
Quality88/100
Evidence: Medium Range p0.0900 – p0.2100

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

AOTI, Inc (AOTI) currently trades at p0.6100, while our model-based Fair Value estimate is p0.1600 — implying the stock looks roughly 73.8% overvalued today. We read business quality at 88/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

AOTI, Inc., together with its subsidiaries, produces, rents, and sells medical devices to resolve severe acute and chronic wounds for customers worldwide. The company offers topical wound oxygen solutions for use in the institutional and the home care settings to improve the health, well-being, and independence of patients; and NEXA, an negative pressure wound therapy system. AOTI, Inc. was incorporated in 2008 and is based in Oceanside, California.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -81% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +19%

Frequently asked questions

Is AOTI, Inc (AOTI) undervalued?
As of Jun 24, 2026, our model estimates a fair value of p0.1600 versus a price of p0.6100 — about −74% (overvalued). Model-based estimate, not financial advice.
What is the fair value of AOTI?
Our 21-model fair value for AOTI, Inc is p0.1600 (as of Jun 24, 2026), built from audited fundamentals. The current price is p0.6100.
What is the quality score of AOTI?
AOTI, Inc has a Quality Score of 88/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.